# Phase II Trial of CHOP-R Followed by Zevalin and Rituxan in Follicular Lymphoma

> **NCT00177554** · PHASE2 · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 60 (actual)

## Conditions studied

- Non-Hodgkin Lymphoma

## Interventions

- **DRUG:** Chemotherapy and Radioimmunotherapy

## Key facts

- **NCT ID:** NCT00177554
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** 2007-05
- **Final completion:** 2007-05
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2008-05-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00177554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00177554, "Phase II Trial of CHOP-R Followed by Zevalin and Rituxan in Follicular Lymphoma". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00177554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*